Floatz logo

dn-101

Colorectal Adenoma

Rockefeller UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Colorectal Adenoma cohort.

Asset / SponsorPhaseRating
Dfn-15
University of Alabama at Birmingham
Phase 2B
Acetylsalicylic Acid
University of Edinburgh
Phase 2CCC
muc1 peptide-poly-iclc vaccine
National Cancer Institute (NCI)
Phase 2CCC
Linaclotide
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2CCC
amr101
Massachusetts General Hospital
Phase 1/2CCC

View all 9 →

Same molecule, other indications

dn-101 is also rated in:

Friedreich AtaxiaDormant
B
Indicative ·
62 / 100
View asset →
PsoriasisDormant
B
Indicative ·
59 / 100
View asset →
Facial AngiofibromaDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →